MiMedx Group, Inc. (NASDAQ:MDXG) is now up 50.65% compared to a 12-month low of $7.64. We have seen the price to move 5.79% higher and get settled at $11.51 on 11/28/2017. At recent session, it appeared stuck in a range of $10.85 to $11.53. This company shares are 65.07% off its target price of $19 and the current market capitalization stands at $1.25B. The recent change has given its price a -6.34% deficit over SMA 50 and -34.12% deficit over its 52-week high. The stock witnessed -5.27% declines, -26.41% declines and -15.86% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found MDXG’s volatility during a week at 5.34% and during a month it has been found around 5.45%.

MiMedx Group, Inc. (MDXG) Top Holders

Institutional investors currently hold around $854 million or 71.7% in MDXG stock. Look at its top three institutional owners. Blackrock Inc. owns $146.45 million in MiMedx Group, Inc., which represents roughly 11.72% of the company’s market cap and approximately 17.15% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 7,561,700 shares of the stock are valued at $82.27 million. The third largest holder is Wellington Management Group Llp, which currently holds $64.09 million worth of this stock and that ownership represents nearly 5.13% of its market capitalization.

MiMedx Group, Inc. 13F Filings

At the end of 09/30/2017 reporting period, 143 institutional holders increased their position in MiMedx Group, Inc. (NASDAQ:MDXG) by some 16,743,804 shares, 74 decreased positions by 6,198,451 and 35 held positions by 55,575,199. That puts total institutional holdings at 78,517,454 shares, according to SEC filings. The stock grabbed 44 new institutional investments totaling 3,772,661 shares while 21 institutional investors sold out their entire positions totaling 881,619 shares.

MiMedx Group, Inc. (NASDAQ:MDXG) Insider Trades

Multiple company employees have indulged in significant insider trading. MiMedx Group, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that President and COO Taylor William Charles has sold 80,000 shares of MiMedx Group, Inc. (MDXG) in trading session dated Jun. 14, 2017. These shares are worth $1,161,600 and were traded at $14.52 each. The SEC filing shows that Taylor William Charles performed a sale of 26,571 shares. The President and COO disposed these shares by way of transaction on May. 25, 2017. The company’s shares were given away at $13.74 per share worth to an income of some $365,086 on account of Taylor William Charles.

President and COO, Taylor William Charles, sold 26,000 common shares of MiMedx Group, Inc. (MDXG) in the open market. In a transaction dated Apr. 27, 2017, the shares were put up for sale at an average price of $11.4, raking in a sum of $296,400. After this sale, 642,656 common shares of MDXG are directly owned by the insider, with total stake valued at $7,396,971.

In the transaction dated Mar. 13, 2017, the great number of shares disposed came courtesy the Director; Koob Charles E disposed a total of 50,486 shares at an average price of $8.5, amounting to approximately $429,131. The insider now directly owns 1,312,306 shares worth $15,104,642.

MiMedx Group, Inc. (MDXG) Analyst Guide

Several analysts have released their opinion on MiMedx Group, Inc. (NASDAQ:MDXG), with 4 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 2 strong sell ratings, collectively assigning a 2.33 average brokerage recommendation.

SHARE
Previous articleWhich insiders are trading Corbus Pharmaceuticals Holdings, Inc. (CRBP)?
Next articleAnalysts Suggest There’s Still Momentum for e.l.f. Beauty, Inc. (ELF), Entravision Communications Corporation (EVC)